IGC PHARMA, INC. Acquisitions, Net of Cash Acquired
IGC PHARMA, INC. (IGC) reported Acquisitions, Net of Cash Acquired of $23.00 thousand for the 6-month period ending 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2019-11-06
- IGC PHARMA, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2019-09-30 was $19.00K, a 137.50% increase year-over-year.
- IGC PHARMA, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2019-06-30 was $4.00K, a 20.00% decline year-over-year.
- IGC PHARMA, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2019-03-31 was $3.00K.
- IGC PHARMA, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2018-12-31 was $29.00K, a 80.54% decline year-over-year.
- IGC PHARMA, INC. payments to acquire businesses, net of cash acquired for fiscal 2019 was $45.00K, a 30.77% decline from fiscal 2018.
- IGC PHARMA, INC. payments to acquire businesses, net of cash acquired for fiscal 2018 was $65.00K.
- IGC PHARMA, INC. payments to acquire businesses, net of cash acquired for fiscal 2017 was $0.00.
- IGC PHARMA, INC. payments to acquire businesses, net of cash acquired for fiscal 2016 was -$16.41K.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 3 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 12 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2019-09-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-06 | $23.00K 10-Q · filed 2019-11-06 | $26.00K derived: sum of 3 quarters · filed 2019-11-06 | $55.00K derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2019-06-30 | $4.00K 10-Q · filed 2019-08-09 | $7.00K derived: sum of 2 quarters · filed 2019-08-09 | $36.00K derived: sum of 3 quarters · filed 2019-08-09 | $44.00K derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2019-03-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-14 | $32.00K derived: sum of 2 quarters · filed 2019-06-14 | $40.00K derived: sum of 3 quarters · filed 2019-11-06 | $45.00K 10-K · filed 2019-06-14 | |||
| 2018-12-31 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-12 | $37.00K derived: sum of 2 quarters · filed 2019-11-06 | $42.00K 10-Q · filed 2019-02-12 | -$179.00K derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2018-09-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-06 | $13.00K 10-Q · filed 2019-11-06 | -$208.00K derived: sum of 3 quarters · filed 2019-11-06 | -$59.00K derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2018-06-30 | $5.00K 10-Q · filed 2019-08-09 | $4.82K 10-Q · filed 2018-08-03 | -$216.00K derived: sum of 2 quarters · filed 2019-08-09 | -$67.00K derived: sum of 3 quarters · filed 2019-08-09 | $70.00K derived: sum of 4 quarters · filed 2019-08-09 | ||
| 2018-03-31 | -$221.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-14 | -$72.00K derived: sum of 2 quarters · filed 2019-06-14 | $65.00K derived: sum of 3 quarters · filed 2019-06-14 | $65.00K 10-K · filed 2019-06-14 | $64.83K 10-K · filed 2018-06-21 | ||
| 2017-12-31 | $149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-12 | $286.00K derived: sum of 2 quarters · filed 2019-02-12 | $286.00K 10-Q · filed 2019-02-12 | $0.00 10-Q · filed 2018-02-20 | $171.57K derived: sum of 4 quarters · filed 2019-02-12 | ||
| 2017-09-30 | $137.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-10-16 | $137.00K 10-Q · filed 2018-10-16 | $22.57K derived: sum of 3 quarters · filed 2018-10-16 | ||||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-03 | -$114.43K derived: sum of 2 quarters · filed 2018-08-03 | |||||
| 2017-03-31 | -$114.43K derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-21 | $0.00 10-K · filed 2018-06-21 | |||||
| 2016-12-31 | $114.43K 10-Q · filed 2018-02-20 | $114.00K 10-Q · filed 2017-02-21 | |||||
| 2016-03-31 | -$16.41K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-14 | -$16.41K derived: sum of 2 quarters · filed 2017-07-14 | -$16.41K derived: sum of 3 quarters · filed 2017-07-14 | -$16.41K 10-K · filed 2017-07-14 | |||
| 2015-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-21 | $0.00 derived: sum of 2 quarters · filed 2017-02-21 | $0.00 10-Q · filed 2017-02-21 | -$414.00 derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-13 | $0.00 10-Q · filed 2015-11-13 | -$414.00 derived: sum of 3 quarters · filed 2016-07-14 | -$568.00 derived: sum of 4 quarters · filed 2016-07-14 | |||
| 2015-06-30 | $0.00 10-Q · filed 2015-08-14 | -$414.00 derived: sum of 2 quarters · filed 2016-07-14 | -$568.00 derived: sum of 3 quarters · filed 2016-07-14 | $1.01K derived: sum of 4 quarters · filed 2016-07-14 | |||
| 2015-03-31 | -$414.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-14 | -$568.00 derived: sum of 2 quarters · filed 2016-07-14 | $1.01K derived: sum of 3 quarters · filed 2016-07-14 | -$165.91K 10-K · filed 2016-07-14 | |||
| 2014-12-31 | -$154.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-16 | $1.42K derived: sum of 2 quarters · filed 2016-02-16 | -$165.49K 10-Q · filed 2016-02-16 | -$165.49K derived: sum of 4 quarters · filed 2016-02-16 | |||
| 2014-09-30 | $1.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-13 | -$165.34K 10-Q · filed 2015-11-13 | -$165.34K derived: sum of 3 quarters · filed 2015-11-13 | -$165.34K derived: sum of 4 quarters · filed 2015-11-13 | |||
| 2014-06-30 | -$166.92K 10-Q · filed 2015-08-14 | -$166.92K derived: sum of 2 quarters · filed 2015-08-14 | -$166.92K derived: sum of 3 quarters · filed 2015-08-14 | -$166.92K derived: sum of 4 quarters · filed 2015-08-14 | |||
| 2014-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-14 | $0.00 derived: sum of 2 quarters · filed 2015-07-14 | $0.00 derived: sum of 3 quarters · filed 2015-07-14 | $0.00 10-K · filed 2015-07-14 | |||
| 2013-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-12 | $0.00 derived: sum of 2 quarters · filed 2015-02-12 | $0.00 10-Q · filed 2015-02-12 | ||||
| 2013-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 | |||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-14 | ||||||
| 2013-03-31 | $0.00 10-K · filed 2014-07-15 | ||||||
| 2012-09-30 | -$308.25K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-11-08 | -$308.25K 10-Q · filed 2013-11-08 | -$308.25K derived: sum of 3 quarters · filed 2014-07-15 | -$2.99M derived: sum of 4 quarters · filed 2014-07-15 | |||
| 2012-06-30 | $0.00 10-Q/A · filed 2012-08-21 | $0.00 derived: sum of 2 quarters · filed 2014-07-15 | -$2.68M derived: sum of 3 quarters · filed 2014-07-15 | -$2.68M derived: sum of 4 quarters · filed 2014-07-15 | |||
| 2012-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-15 | -$2.68M derived: sum of 2 quarters · filed 2014-07-15 | -$2.68M derived: sum of 3 quarters · filed 2014-07-15 | -$2.68M 10-K · filed 2014-07-15 | |||
| 2011-12-31 | -$2.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-13 | -$2.68M derived: sum of 2 quarters · filed 2013-02-13 | -$2.68M 10-Q · filed 2013-02-13 | ||||
| 2011-09-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | |||||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |